Aug 02, 2022 / 12:00PM GMT
Operator
Good morning. My name is Charlie, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Blueprint Medicines Second Quarter 2020 Financial Results Conference Call. (Operator Instructions)
Jenna Cohen, you may begin your conference.
Jenna Cohen - Blueprint Medicines Corporation - Senior Director & Head of IR
Thank you, Charlie. Good morning, everyone, and welcome to Blueprint Medicines Second Quarter 2022 Financial and Operating Results Conference Call. This morning, we issued a press release, which outlines the topics we plan to discuss today. You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our website at www.blueprintmedicines.com.
Joining me on today's call are Kate Haviland, our Chief Executive Officer, who will discuss our successes in the second quarter and a look ahead to the second half of the year; Philina Lee, our Chief Commercial Officer, who
Q2 2022 Blueprint Medicines Corp Earnings Call Transcript
Aug 02, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers